Related Experiment Video
Updated: Jun 3, 2026
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Published on: April 15, 2014
Chronic mild hypoxia ameliorates chronic inflammatory activity in myelin oligodendrocyte glycoprotein (MOG) peptide
Paula Dore-Duffy1, Marie Wencel, Vladimir Katyshev
1Department of Neurology, Division of Immunology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. pdduffy@med.wayne.edu
Abstract:
While the pathologic events associated with multiple sclerosis (MS), diffuse axonal injury, cognitive damage, and white matter plaques, have been known for some time, the etiology of MS is still unknown and therapeutic efforts are somewhat disappointing. This may be due to a lack of fundamental knowledge on how to buffer the brain from secondary injury following immune attack. Maintenance of central nervous system (CNS) homeostasis is a complex set of regulatory adjustments by the neurovascular unit that includes induction of adaptive angiogenesis. Although aspects of adaptive angiogenesis are induced in MS and experimental autoimmune encephalomyelitis (EAE), vascular remodeling is ineffective and the balance between metabolic need and oxygen (O(2)) and glucose availability is disrupted.We hypothesized that restoration of metabolic homeostasis in the CNS would ameliorate tissue damage and promote repair in myelin oligodendrocyte glycoprotein(MOG)-induced EAE in mice. Exposure of animals to chronic mild hypoxia (10% O(2)) increased vascular density and significantly delayed onset and severity of clinical EAE. When animals were exposed to hypoxia after the onset of clinical symptoms, the severity of chronic inflammatory disease was reduced or even inhibited. In addition, spinal cord pathology was decreased.While the mechanism of protection is unclear, results suggest that hypoxia has therapeutic potential in EAE.
Insights
Hypoxia therapy, or low oxygen exposure, may offer a new treatment for multiple sclerosis (MS). Studies show it can reduce disease severity and spinal cord damage in mouse models, suggesting potential therapeutic benefits.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Multiple sclerosis (MS) involves brain damage, but its cause and effective treatments remain elusive.
- Current therapeutic strategies for MS are limited by a lack of understanding regarding brain protection from secondary injury.
- Maintaining central nervous system (CNS) homeostasis involves adaptive angiogenesis, which is often ineffective in MS and experimental autoimmune encephalomyelitis (EAE).
Purpose of the Study:
- To investigate whether restoring metabolic homeostasis through hypoxia could mitigate tissue damage and promote repair in a mouse model of MS (MOG-induced EAE).
Main Methods:
- Mice with MOG-induced EAE were exposed to chronic mild hypoxia (10% O(2)) either before or after the onset of clinical symptoms.
- Vascular density and clinical EAE severity were assessed.
- Spinal cord pathology was evaluated to determine the extent of tissue damage.
Main Results:
- Hypoxia exposure increased vascular density in the CNS.
- Pre-symptomatic hypoxia significantly delayed the onset and reduced the severity of clinical EAE.
- Hypoxia administered after symptom onset reduced chronic inflammatory disease severity and decreased spinal cord pathology.
Conclusions:
- Restoring metabolic homeostasis via hypoxia shows therapeutic potential in experimental autoimmune encephalomyelitis (EAE).
- Hypoxia may ameliorate tissue damage and promote repair in MS by improving CNS metabolic balance and vascularization.
- Further research is needed to elucidate the precise mechanisms underlying hypoxia's protective effects in EAE.
More Related Videos
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016